Evaluation of effect of spironolactone on proteinuria in kidney transplant patients
Phase 4
- Conditions
- Proteinuria.Glomerular disorders in diseases classified elsewhere
- Registration Number
- IRCT20230516058205N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Persons with more than three months after kidney transplantation
Proteinuria more than 0.5 gram per day
Estimated glomerular filtration rate more than 30 mili liter per minute
Consent to participate in study
Exclusion Criteria
Serum potassium more than 5.5
Gynechomastia
Transplant dysfunction(eGFR<30)
Spironolactone usage for heart and liver failure
sensitivity to spironolactone
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rine protein. Timepoint: Monthly. Method of measurement: 24 hours urine sample.
- Secondary Outcome Measures
Name Time Method